The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines.
about
UPCI-SCC-002UPCI-SCC-003UPCI-SCC-013UPCI-SCC-016UPCI-SCC-026UPCI-SCC-029AUPCI-SCC-030UPCI-SCC-032UPCI-SCC-036UPCI-SCC-040UPCI-SCC-044UPCI-SCC-045UPCI-SCC-051UPCI-SCC-052UPCI-SCC-053UPCI-SCC-056UPCI-SCC-062UPCI-SCC-065UPCI-SCC-066UPCI-SCC-068UPCI-SCC-070UPCI-SCC-072UPCI-SCC-074UPCI-SCC-075UPCI-SCC-077UPCI-SCC-078UPCI-SCC-080UPCI-SCC-081UPCI-SCC-084UPCI-SCC-089UPCI-SCC-090UPCI-SCC-099UPCI-SCC-103UPCI-SCC-104UPCI-SCC-105UPCI-SCC-111UPCI-SCC-114UPCI-SCC-116UPCI-SCC-121UPCI-SCC-122
P1343
Estrogen and cytochrome P450 1B1 contribute to both early- and late-stage head and neck carcinogenesisOverexpression of KLF13 and FGFR3 in oral cancer cells.Deficiency in myosin light-chain phosphorylation causes cytokinesis failure and multipolarity in cancer cells.UM-SCC-103: a unique tongue cancer cell line that recapitulates the tumorigenic stem cell population of the primary tumorDefining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer.Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature.Primary microcephaly gene MCPH1 shows signatures of tumor suppressors and is regulated by miR-27a in oral squamous cell carcinoma.Oncogenic human papillomavirus-associated nasopharyngeal carcinoma: an observational study of correlation with ethnicity, histological subtype and outcome in a UK population.Regulation of the tumour suppressor PDCD4 by miR-499 and miR-21 in oropharyngeal cancers.UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell lineOral human β-defensin 2 in HIV-infected subjects with long-term use of antiretroviral therapySelective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer.Changes in oral cytokeratin expression in HIV-infected subjects with long-term use of HAART.DNA double strand break repair defect and sensitivity to poly ADP-ribose polymerase (PARP) inhibition in human papillomavirus 16-positive head and neck squamous cell carcinoma.The chemopreventive and clinically used agent curcumin sensitizes HPV (-) but not HPV (+) HNSCC to ionizing radiation, in vitro and in a mouse orthotopic model.MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features.Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancyExpression of oral cytokines in HIV-infected subjects with long-term use of antiretroviral therapy.Multiparameter Evaluation of the Heterogeneity of Circulating Tumor Cells Using Integrated RNA In Situ Hybridization and Immunocytochemical Analysis.Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma.Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instabilityViral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines.Cancer stem cell markers in patterning differentiation and in prognosis of oral squamous cell carcinoma.The primary growth of laryngeal squamous cell carcinoma cells in vitro is effectively supported by paired cancer-associated fibroblasts alone.Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines.Novel method of cell line establishment utilizing fluorescence-activated cell sorting resulting in 6 new head and neck squamous cell carcinoma lines.Methyl-donor depletion of head and neck cancer cells in vitro establishes a less aggressive tumour cell phenotype.Bortezomib sensitises TRAIL-resistant HPV-positive head and neck cancer cells to TRAIL through a caspase-dependent, E6-independent mechanism.Increased sensitivity of HPV-positive head and neck cancer cell lines to x-irradiation ± Cisplatin due to decreased expression of E6 and E7 oncoproteins and enhanced apoptosis.Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis.Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.Upregulation of the ATR-CHEK1 pathway in oral squamous cell carcinomas.ERK1/2 regulation of CD44 modulates oral cancer aggressiveness.Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer.Cell division patterns and chromosomal segregation defects in oral cancer stem cells.Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines.Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines.Viral E6/E7 oncogene and cellular hexokinase 2 expression in HPV-positive cancer cell lines.Hypoxia-inducible factor-1α activation in HPV-positive head and neck squamous cell carcinoma cell lines.Recurring Amplification at 11q22.1-q22.2 Locus Plays an Important Role in Lymph Node Metastasis and Radioresistance in OSCC.
P2860
Q54991557-C4B90B5C-B424-4B63-BB77-B96BA59B57D7Q54991560-6335002A-0613-49EB-9561-C94F292B67A5Q54991562-58D690DC-101F-4916-8F74-A2115E63CA7FQ54991564-98E617D5-17B8-4865-AC59-0D4F631754B5Q54991567-BEA1302C-7E3F-47D8-B3C7-D349A8F83D2BQ54991569-E062B0BF-18A1-4BB3-A851-C50DFC396FD1Q54991570-0783E25D-4233-4707-8354-657D7D5907AFQ54991572-E081D0FC-9B4A-4C30-B11A-2B51E27DD756Q54991573-490981C2-3258-4DE0-AFF4-1F4FA5222685Q54991575-D77B2BCE-019C-47E1-B0B9-020891C87C94Q54991577-96E7FD79-1AB7-4440-BC33-0E007E74DE03Q54991580-9666D69E-9CA7-4328-9201-7915C65E5691Q54991582-55F59A34-9DD1-4D72-AFD3-4D6BF04BA0E4Q54991584-123A6CF7-A893-4327-A61B-1FD687BA0696Q54991586-ABDBA42F-590A-49E2-ADF8-BCF69743A73EQ54991588-C2228534-6B60-4B4C-A9A3-2423AEC3B58CQ54991591-10F173B2-0220-4BDD-AEBF-4C981FBAD31AQ54991593-5EA05F70-6593-4F1A-AF2F-A13717B2FBD0Q54991596-C9AAA736-0A02-4257-802F-23532FDFA55EQ54991597-E397B7DA-8CFC-4FFF-9563-38273D9A28E0Q54991599-73F3B90D-C15E-4534-91C5-2E8C86AB1177Q54991601-ABBC2309-6B67-4427-A331-F20AB538BB55Q54991604-8A43CD53-B569-4562-9CC9-BF3F96F7AC12Q54991606-00A99DCD-165A-4B58-9D66-45B38A0346C5Q54991608-6340C724-B440-4E79-9FF0-5B8E97BC2C22Q54991610-086C092B-9C23-4B88-8D48-2F77811086FBQ54991613-AB810379-F580-483B-B381-F7EC77CC6348Q54991652-75442FDE-83B3-4004-9414-FC10680C2B2DQ54991654-66E5920B-7E9F-43AF-9A7F-43EA0287E203Q54991656-2A0FEEA0-FBA1-4C64-BDBF-6EF21C75DEA4Q54991658-4F65FC0E-A989-47F6-8A5E-015BB9472ABBQ54991660-038E7198-A885-4BDD-98AA-919379D4158EQ54991662-4609FD6B-5DA3-43DE-ACC4-0C9C71B77D4BQ54991664-272C2211-C2AD-48C1-AD6C-200B668C3250Q54991667-3E8C22C9-22C6-48B0-8CCF-43B9AB801C2BQ54991668-E4C9F892-92F0-4AA6-A33D-60B558955122Q54991670-DD07EAEA-A0B8-449D-A4AC-4AB980542091Q54991671-7785D3F6-78F0-4D2F-9B0A-4EAD59C0DAB7Q54991673-49BB8233-4753-4D8D-B946-D8D9CF4790E8Q54991674-87798306-A81B-4224-BE2A-727B4660D995
P1343
Q30498225-4499CDAF-690B-4107-94AD-0535B1355DC4Q33928136-FE6FA9DA-2BF8-4E4B-BDE5-57828C41F6E9Q34026048-ADD80BB1-CD69-43C2-9200-F5D12FE52DB3Q34127978-C1BF91C8-638A-4D0C-ABFE-DAD9178FA16BQ34303695-0D2906A3-EA6C-43CB-A72F-8650EBD6583DQ34581690-5AAF0334-E2F2-4F38-8AF7-A50FB4BF2484Q34614246-05704E1E-6BCE-44B4-AC4E-E7CAADADE9C3Q34929629-3F37C5B6-D88D-43A8-88B0-EBCC7874E5D1Q35921160-65343740-8BAB-4CAC-B663-D0A4EA36A8FCQ36013039-75FFD11B-DF71-46EF-804D-F84CB2856091Q36243619-1EBB912B-0FC4-436E-B774-58D71A79C5E5Q36297882-4D06270C-3E58-4075-B968-09744D7AA8F7Q36369112-513737A2-22A3-45F7-A07D-EEFC099F1D1EQ36413681-31213DEA-D7AF-44F0-AAAE-FA93FCF82045Q36504144-ECF46BE7-01B7-456F-BAE4-E876B7026BFAQ36764848-CDF5AF96-7287-4641-84EB-0A31EC9FCAC4Q37305438-57C5FFCC-F900-49D1-A688-E320D4D59941Q37384307-3B031D60-A5EF-4FDB-8870-F559CCA64FF0Q37398787-4CEF3804-A1F6-4339-AC2A-95303AD95417Q37549460-10BE9C51-84B8-4236-B372-AE66D0964AC0Q37550193-E93F2CC3-4084-447A-9434-3B4332544290Q37726485-52EDF6C4-ABC9-4F6C-A5C8-7A78FB9A875AQ38699708-7C18C9B3-5DAA-4A2E-8AD3-3A458EE3ECCCQ38704743-C893F72B-562D-4474-AD19-22B2B02DE65CQ38724749-FBFBB5EE-01D7-45AD-99B5-A58CCF081ED4Q38910205-DFA0B2AF-D8C6-4E50-84CA-76AF1BDB91A5Q38934431-C35F21D1-5046-4477-8715-6DB7DC8D649BQ38945539-57C8FCF4-EF50-4C6B-AECC-98A43F6C10E5Q38999029-956221EF-30F6-42C4-93AA-6DC66B9A1588Q39006076-762B9735-D069-48F6-A3FB-4DFE6D7D9CE1Q39044559-8441CD4C-741B-4519-AD15-C3C8F2E2AADBQ39076159-D53C4B61-1248-40AB-8666-F8580852F7C7Q39442395-2BE1BCE0-EBBD-4226-B612-465D6B27601FQ39466612-8C04187E-033B-436A-A8E7-9A54EFB312ADQ39814561-8B204EED-928F-49DF-9CF2-69DBD27E8356Q40319208-0EC822F9-CDBC-4E2F-9F3A-594F549CC275Q44444441-52C7AAE3-6BA3-4B05-82B9-AC3A54272331Q47104746-D5F93314-03A0-450E-9F63-B6E1C0625978Q47120363-463FB09C-5D65-41EE-90B5-7DA5CFAA3726Q47134212-F8539C46-3F23-4D44-AFA0-53E7F795DDF4
P2860
The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The influence of clinical and ...... ous cell carcinoma cell lines.
@ast
The influence of clinical and ...... ous cell carcinoma cell lines.
@en
type
label
The influence of clinical and ...... ous cell carcinoma cell lines.
@ast
The influence of clinical and ...... ous cell carcinoma cell lines.
@en
prefLabel
The influence of clinical and ...... ous cell carcinoma cell lines.
@ast
The influence of clinical and ...... ous cell carcinoma cell lines.
@en
P2093
P2860
P4510
P1433
P1476
The influence of clinical and ...... ous cell carcinoma cell lines.
@en
P2093
Camille C R Ragin
Chandramohan S Ishwad
Eugene N Myers
Jason S White
Joel L Weissfeld
John C Law
Jonas T Johnson
Karen M Rossie
Michele Shuster
P2860
P304
P356
10.1016/J.ORALONCOLOGY.2006.09.001
P407
P4510
P577
2006-11-16T00:00:00Z